Pilot Study of Effect of Kaletra on CD4 Response in HIV Positive (+) Patients With Viral Suppression KIMBO Study
Status:
Terminated
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
To explore the hypothesis that the use of Lopinavir/ritonavir will be associated with
improved CD4 immune reconstitution in volunteers who fail to demonstrate a significant CD4
cell increase (while on their first antiretroviral treatment regimen) despite sustained viral
suppression by a non-Lopinavir/ritonavir-containing regimen
Phase:
N/A
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore